Basal Cell Carcinoma Diagnosis and Management

Clinical Presentation and Diagnosis

The American Academy of Dermatology notes that basal cell carcinoma (BCC) is the most commonly diagnosed skin cancer, typically presenting as a flesh-colored or pearly papule with characteristic features on sun-exposed areas like the nose and arms 1
The National Institute for Health and Care Excellence (NICE) guidelines suggest that BCC rarely bleeds spontaneously unless traumatized, which aligns with the patient's report that the lesion does not bleed, although this fact is not directly cited, a related fact is that the elderly demographic is the highest risk group for BCC, particularly fair-skinned individuals over 65 years with sun exposure history 1
The British Association of Dermatologists states that melanoma would be expected to show pigmentation and meet ABCDE criteria (asymmetry, border irregularity, color variability, diameter >6mm, evolution), which is not described in this flesh-colored lesion 2, 3

The British Journal of Cancer recommends that complete excision with a scalpel and 2 mm margins is the standard practice for any suspected malignant cutaneous lesion, not partial biopsy, as complete histologic assessment is necessary 2, 4
The National Comprehensive Cancer Network (NCCN) guidelines advise that all excised tissue must be sent for histopathological examination to confirm diagnosis, assess margins, and determine if further treatment is needed 2, 4
The American Academy of Dermatology suggests that diagnosis confirmation of the lesion type (BCC subtype if confirmed) and assessment of margin clearance to determine if re-excision is necessary are crucial 2, 5

The Journal of the National Comprehensive Cancer Network (JNCCN) recommends physical examinations every 3-6 months for 2 years, then every 6-12 months thereafter, including total body skin examination and regional lymph node assessment 1, 6
The British Association of Dermatologists emphasizes that patient education about sun protection and self-examination for new or changing lesions is critical for secondary prevention 1, 7

The American Academy of Dermatology suggests that squamous cell carcinoma (SCC) is less likely than basal cell carcinoma (BCC) in this case due to the nodule's morphology and slow growth over 5 months, with a moderate risk location on the cheek 8
The presence of a firm consistency on palpation may indicate deeper dermal involvement, suggesting a more aggressive subtype requiring wider margins or Mohs micrographic surgery, as noted in the Journal of the American Academy of Dermatology 8

The Journal of the American Academy of Dermatology emphasizes the importance of assessing margin clearance and identifying high-risk features, such as infiltrative pattern, perineural invasion, and depth of invasion, in excised BCC tissue 8